Company intelligence / Profile preview
L&L Biopharma Co., Ltd.
Shanghai, Shanghai, Chinalnlbio.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Phase 2
01
Overview
The company has multiple programs in preclinical and clinical stages, with at least 2 programs in Phase 2 trials as of May 2025
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodiesBispecific antibodiesTrispecific antibodiesCAR-T cell therapy
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Beyond the preview
Go deeper on L&L Biopharma Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L&L Biopharma Co., Ltd..